Asimov employs artificial intelligence to develop tools for the design and manufacture of next-generation therapeutics.
Asimov has raised $175.0M in total funding. The most recent round was Series B. The last funding was announced in January 2023.
Asimov's investors include Andreessen Horowitz, K5 Global, Wing Venture Capital, Pillar VC, Fidelity.
Asimov is headquartered in Boston, United States.
Asimov employs artificial intelligence to develop tools for the design and manufacture of next-generation therapeutics.
Asimov is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Asimov — Funding & Investors." VCBacked, January 5, 2023, https://www.vcbacked.co/company/asimov. Accessed August 14, 2026.
VCBacked. (2023). Asimov — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/asimov
{{cite web |title=Asimov — Funding & Investors |url=https://www.vcbacked.co/company/asimov |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated